Navigation Links
U of M discovery to improve efficiencies in fuel, chemical and pharmaceutical industries
Date:6/28/2012

MINNEAPOLIS / ST. PAUL (06/28/2012) University of Minnesota engineering researchers are leading an international team that has made a major breakthrough in developing a catalyst used during chemical reactions in the production of gasoline, plastics, biofuels, pharmaceuticals, and other chemicals. The discovery could lead to major efficiencies and cost-savings in these multibillion-dollar industries.

The research is to be published in the June 29, 2012 issue of the leading scientific journal Science.

"The impact of this new discovery is enormous," said the team's lead researcher Michael Tsapatsis, a chemical engineering and materials science professor in the University of Minnesota College of Science and Engineering. "Every drop of gasoline we use needs a catalyst to change the oil molecules into usable gasoline during the refining process."

This research improves efficiencies by giving molecules fast access to the catalysts where the chemical reactions occur. Tsapatsis compared it to our use of freeways and side streets in our daily lives.

"It's faster and more efficient to use freeways to get where we want to go and exit to do our business compared to driving the side streets the entire way," he explained. "The catalysts used today are more like all side streets. Molecules move slowly and get stuck. The efficiencies of these new catalysts could lower the costs of gasoline and other products for all of us."

The research team built their prototype of the new catalyst using highly optimized ultra-thin zeolite nanosheets. They used a unique process to encourage growth of these nanosheets at 90-degree angles, similar to building a house of cards. The house-of-cards arrangement of the nanosheets makes the catalyst faster, more selective and more stable, but can be made at the same cost (or possibly cheaper) than traditional catalysts.

With faster catalysts available at no extra cost to the producer, production per manufacturing dollar will increase. With a higher output, it is conceivable that consumer costs will drop.

This new discovery builds upon previous discoveries at the University of Minnesota of ultra-thin zeolite nanosheets used as specialized molecular sieves for production of both renewable and fossil-based fuels and chemicals. These discoveries, licensed by the new Minnesota start-up company Argilex Technologies, are key components of the company's materials-based platform. The development of the new catalyst is complete, and the material is ready for customer testing.

"This breakthrough can have a major impact on both the conversion of natural gas to higher value chemicals and fuels, and on bio- and petroleum refiners," said Cesar Gonzalez, CEO of Argilex Technologies. "Using catalysts made by this novel approach, refiners will be able to obtain a higher yield of desirable products such as gasoline, diesel, ethylene and propylene. At Argilex, we envision this catalyst technology platform to become a key contributor to efficient use of natural resources and improved economics of the world's largest industries."

Researchers on the team are from around the globe. In addition to the University of Minnesota, researchers are from institutions in Tokyo, Abu Dhabi, Korea and Sweden.


'/>"/>

Contact: Rhonda Zurn
rzurn@umn.edu
612-626-7959
University of Minnesota
Source:Eurekalert

Related biology technology :

1. Discovery of material with amazing properties
2. Dr. Victor Ambros and Dr. Gary Ruvkun Win 2012 Dr. Paul Janssen Award for Biomedical Research for Discovery of MicroRNAs
3. Discovery Labs to Present AFECTAIR® Data at European Congress on Pediatric and Neonatal Ventilation
4. Discovery Labs Reports First Quarter 2012 Financial Results
5. Genomic Health and OncoMed Announce Strategic Alliance for Biomarker Research and Discovery Using Next Generation Sequencing
6. AnaptysBio Announces Antibody Discovery Partnership With Gilead Sciences
7. UWM discovery advances graphene-based electronics
8. Mars, Incorporated Answers Question: How Does Feeding People and Pets Nurture Science and Discovery? At TEDMED 2012
9. AlphaBio Centrix, LLC Announces a New Discovery for Programming Energetic Patches
10. Discovery in Nature elucidates immune cells in skin and supports novel vaccine approach
11. Thomson Reuters Cortellis Drives Drug Discovery and Development With Powerful New Web Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
(Date:2/16/2017)... and NEW YORK , Feb. 16, ... completion of their $7M Series B financing, adding an ... the $3.5M led by Mesa Verde Venture Partners and ... resources will be directed towards further accelerating commercial adoption ... comprehensive genomic profiling test and expanding the Paradigm cancer ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. ... Biotech, Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung ... Klasse führenden Plattform für die Entdeckung monoklonaler Antikörper. ... ihr neuartiges chimäres Gensegmentdesign aus, das Janssen ... humanen Antikörpern bietet und das für die schelle ...
(Date:2/15/2017)... -- Windtree Therapeutics, Inc. (Nasdaq: WINT ), ... therapies for respiratory diseases, will host a conference call ... EST on Thursday, February 16, 2017 to provide updates ... announced closing of a $10.5 million private offering and ... in the live call and take part in the ...
Breaking Biology Technology:
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to its ... meaningful advances worldwide, The Japan Prize Foundation today ... who have pushed the envelope in their respective ... Communication. Three scientists are being recognized with the ... that not only contribute to the advancement of ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
Breaking Biology News(10 mins):